PrEPVacc HIV vaccine trial shows no reduction in infections

FHS
July 23, 2024
1:01 pm

The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show conclusively that neither of the two experimental vaccine regimens tested reduced HIV infections among the study population.

What to Know About Delta-8 and Other Common Vape Shop Drugs

They’re sold in gas stations, vape shops, online, and in other stores around the country in seemingly countless enticing forms: gummies, chocolate bars, chips. Their

September 5, 2024

California lawmakers approve nation-leading $25 minimum wage for health workers

A sweeping agreement between labor and the health industry would gradually raise the minimum wage for hundreds of thousands of health workers in California to

September 15, 2023

SMART trial shows comparable outcomes of two common TAVR devices in small aortic annulus patients

People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the aorta, who underwent transcatheter aortic valve replacement

April 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.